Comparison between Parabolic Drugs IPO and Technofab Engineering IPO.
Parabolic Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Technofab Engineering IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Parabolic Drugs IPO is up to ₹200.00 Cr whereas the issue size of the Technofab Engineering IPO is up to ₹71.66 Cr. The final issue price of Parabolic Drugs IPO is ₹75.00 per share and of Technofab Engineering IPO is ₹240.00 per share.
| Parabolic Drugs IPO | Technofab Engineering IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹75.00 per share | ₹230.00 per share |
| Issue Price (Upper) | ₹85.00 per share | ₹240.00 per share |
| Issue Price (Final) | ₹75.00 per share | ₹240.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | ₹20.00 per share |
| Market Lot Size | 80 shares | 25 shares |
| Fresh Issue Size | 2,46,40,965 shares | 29,90,000 shares |
| Fresh Issue Size (Amount) | up to ₹184.81 Cr | up to ₹71.66 Cr |
| OFS Issue Size | 20,25,702 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹15.19 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,66,66,667 shares | 29,90,000 shares |
| Issue Size Total (Amount) | up to ₹200.00 Cr | up to ₹71.66 Cr |
Parabolic Drugs IPO opens on Jun 14, 2010, while Technofab Engineering IPO opens on Jun 29, 2010. The closing date of Parabolic Drugs IPO and Technofab Engineering IPO is Jun 17, 2010, and Jul 02, 2010, respectively.
| Parabolic Drugs IPO | Technofab Engineering IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jun 14, 2010 | Jun 29, 2010 |
| Issue Close | Jun 17, 2010 | Jul 02, 2010 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jul 01, 2010 | Jul 16, 2010 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Parabolic Drugs IPO P/E ratio is , as compared to Technofab Engineering IPO P/E ratio of .
| Parabolic Drugs IPO | Technofab Engineering IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.21 | 51 | ||||
| Promoter Shareholding (Post-Issue) | 38.04 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹464.19 Cr. | ₹251.76 Cr. | ||||
| ROE | ||||||
| ROCE | 6.21 | |||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 19.96 | 38.2 |
In the Parabolic Drugs IPO Retail Individual Investors (RII) are offered 91,58,334 shares while in Technofab Engineering IPO retail investors are offered 91,58,334 shares. Qualified Institutional Buyers (QIB) are offered 1,30,83,333 shares in Parabolic Drugs IPO and 14,70,000 shares in Technofab Engineering IPO.
| Parabolic Drugs IPO | Technofab Engineering IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 1,30,83,333 shares | 14,70,000 shares |
| NII | 39,25,000 shares | 4,41,000 shares |
| RII | 91,58,334 shares | 10,29,000 shares |
| Employee | 5,00,000 shares | 50,000 shares |
| Others | ||
| Total | 2,66,66,667 shares | 29,90,000 shares |
Parabolic Drugs IPO subscribed 1.04x in total, whereas Technofab Engineering IPO subscribed 12.78x.
| Parabolic Drugs IPO | Technofab Engineering IPO | |
|---|---|---|
| QIB (times) | 1.48x | 4.28x |
| NII (times) | 1.20x | 48.85x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.40x | 10.03x |
| Employee (times) | 0.11x | 1.10x |
| Other (times) | ||
| Total (times) | 1.04x | 12.78x |
